ArticleJTO clinical and research reports2026

Immune Checkpoint Inhibitor Outcomes in NSCLC Across Populations and Practice Settings.

Matthew Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.